GlassScriptPhysician profile
Lee S Pollack
NPI 1588757462
$5,672.83
in general payments reported to CMS, 2019-2025
46 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,341 · 2020: $1,361 · 2021: $1,759 · 2022: $213.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $797.66 | 2019-2022 | |
| Emd Serono, INC. | $593.34 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $466.34 | 2019-2021 | |
| Adamas Pharmaceuticals, INC. | $352.59 | 2019-2021 | |
| Biogen, INC. | $248.12 | 2019-2021 | |
| Csl Behring | $222.92 | 2019-2021 | |
| Ucb, INC. | $222.22 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $188.95 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $175.76 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $172.15 | 2019-2020 | |
| Genzyme Corporation | $171.49 | 2019 | |
| Lilly USA, LLC | $158.83 | 2019-2021 | |
| Neurelis, INC. | $140.52 | 2020-2022 | |
| Aquestive Therapeutics, INC. | $127.49 | 2019-2022 | |
| Abbvie INC. | $118.47 | 2021-2022 |
Show all 46 companies
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Pollack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.